Dutasteride and Tamsulosin Hydrochloride
Dutasteride and Tamsulosin Hydrochloride Capsules · DUTASTERIDE .5 mg/1; TAMSULOSIN HYDROCHLORIDE .4 mg/1 · Capsule · Oral · AvKARE
NDC 42291-0031-30 · 30 CAPSULE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA202509
- TE code
- AB
- Approval date
- Feb 26, 2014
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Dutasteride and Tamsulosin Hydrochloride Capsules (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AvKARE | DUTASTERIDE .5 mg/1; TAMSULOSIN HYDROCHLORIDE .4 mg/1 | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Dutasteride and Tamsulosin Hydrochloride — NDC 42291-0031-30," retrieved September 3, 2026, https://drugdashboards.com/drug/42291003130.
Free to cite with attribution — see how the data is put together.